Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II;Sinusvenenthrombose. Eine seltene Komplikation einer Heparin-induzierten ThrombozytopenieTyp II

Anaesthesist

Volumn 53, Issue 6, 2004, Pages 551-554

  Merz, S ^a,b   Fehr, R ^a   Gulke C ^a  

^a Klin Anasthesiologie I   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

Author keywords

Danaparoid; Heparin induced thrombocytopenia type II; Sinus vein thrombosis; Unfractionated heparin

Indexed keywords

DANAPAROID; HEPARIN;

ARTERY THROMBOSIS; ARTICLE; CLINICAL FEATURE; CONVULSION; HEADACHE; HUMAN; NAUSEA; THROMBOCYTOPENIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ANTICONVULSANTS; BLOOD CELL COUNT; CHONDROITIN SULFATES; DERMATAN SULFATE; DRUG COMBINATIONS; HEPARIN; HEPARITIN SULFATE; HUMANS; MALE; MENTAL DISORDERS; POSTOPERATIVE COMPLICATIONS; SEIZURES; SINUS THROMBOSIS, INTRACRANIAL; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042835952     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Admiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia. Thromb Haemost 68:95-96
2. Andreescu A, Chushman M (2000) Case studies in heparin-induced thrombocytopenia. J Thromb Thrombolysis 10 [Suppl 1]:71-76
3. Brenske M, Tarnow J (1998) Heparin-induzierte Thrombozytopenie. Anastnesiol Intensivmed Notfallmed Schmerzther 33:411-416
4. Bundesinstitut für Arzneimittel und Medizinprodukte (1996) B-782 Thrombose-Risiko bei relativer Heparin-assoziierter Thrombozytopenie. Dtsch Arztebl 93, Heft 15
5. Calhoun BC, Hesser JW (1987) Heparin-associated antibody with pregnancy: discussion of two cases. Am J Obstet Gynecol 156:964-966
6. Chong BH (1995) Heparin-induced thrombocytopenia. Br J Haematol 86:431-439
7. Chong BH, Fawaz I, Chesterman CN, Berndt MC (1989) Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235-240
8. Greinacher A (1996) Heparin-induzierte Thrombocytopenien. Internist 37:1172-1178
9. Greinacher A (2002) Antikoagulation bei HIT II: Wann therapeutisch - wann prophylaktisch? Anasthesiol Intensivmed Notfallmed Schmerzther 37 [Suppl I]:3-7
10. Greinacher A, Admiral J, Dummel V, Vissac M, Kiefel V, Müller-Eckardt C (1994) Laboratory diagnosis of heparin-associated thrombocytopenia, comparison of platelet aggregation test, heparin-induced platelet activation (HIPA) test, and PF4/heparin ELISA. Transfusion 34:381-385
11. Hermanns B, Janssens U, Handt S, Füzesi L (1998) Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome). Vircnows Arch 432:541-546
12. Hirsh J, Warkentin TE, Raschke R et al. (1998) Heparin and low-molecular weight heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 114 [Suppl 5]:489-510
13. Kelton JG (1989) Heparin induced thrombocytopenia. Haemostasis 16:173-186
14. Kyritsis AP, Williams EC, Schutta HS (1990) Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 21:1503-1505
15. Lecompte T (1991) Thrombocytopenia associated with low molecular weight heparin. Lancet 338:12-17
16. Magnani HN (1993) Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Hemost 70:554-561
17. Meyer-Lindenberg A, Quenzel EM, Bierhoff E, Wolff H, Schindler E, Biniek R (1997) Fatal cerebral venous sinus thrombosis in heparin induced thrombotic thrombopenia. Eur Neurol 37:191-192
18. Pohl C, Harbrecht U, Greinacher A, Theuerkauf I, Biniek R, Hanfland P, Klockgether T (2000) Neurologic complications in immune-mediated heparin-induced thrombocytopenia. Neurology 54:1240-1245
19. Rhodes G, Dixon R, Silver D (1977) Heparin-induced thrombocytopenia: eight cases with thrombotic-haemorrhagic complications. Ann Surg 186:752-758
20. Rott H (2003) Antikoagulation und HIT Refresher Course. Aktuelles Wissen für Anästhesisten:95-108
21. Scheffold N, Maitra R, Cyran J (1998) Heparin-induzierte Thrombozytopenie. Schweiz Med Wochenschr 128:609-615
22. Scheffold N, Schöngart H, Berentelg J, Prager P, Cyran J (2001) Seltene Komplikation einer Heparin-induzierten Thrombozytopenie Typ II (HIT II). Dtsch Med Wochenschr 126:329-333
23. Sheridan D, Carter C, Kelton JG (1986) A diagnostic test of heparin-induced thrombocytopenia. Blood 67:27-30
24. Stevenson M (1976) Thrombocytopenia during heparin therapy. N Engl J Med 295:1200-1201
25. Stricker H, Mombelli G (1999) Hautnekrosen, Thrombozytopenie und tiefe Beinvenenthrombose unter subcutaner Thramboembolieprophylaxe mit Heparin: Heparininduzierte Thrombozytopenie (HIT) Typ II. Therapeut Umschau 56:484-486
26. Walter EU (1996) Cranial sinus thrombosis associated with essential thrombocytopenia followed by heparin associated thrombocytopenia. Neurology 47:300-301
27. Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286-1292
28. Warkentin TE, Bernstein RA (2003) Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administation of unfractionated heparin. N Engl J Med 348:1067-1068
29. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton J (1995) Heparin induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335
30. Weyden MB van der, Hunt H, McGrath K, Fawcett T, Fitzmaurice A, Sawers RJ, Rosengarten DS (1983) Delayed-onset heparin-induced thrombocytopenia: a potentially malignant syndrome. Med J Aust 2:132-135
31. Weissmann RE, Tobin R (1958) Arterial embolism occuring during systemic heparin therapy. Arch Surg 76:219-227